Akeso is Rapidly Advancing The Phase II Clinical Trial of IL-4R Monoclonal Antibody (AK120) for the Treatment of Atopic Dermatitis and Asthma
HONG KONG, Oct. 15, 2021 /PRNewswire/ -- Akeso, Inc. (the Company, 9926.HK) announces that the Company's self-developed innovative drug candidate, IL-4R monoclonal antibody (AK120), was approved by the Center for Drug Evaluation (CDE) of the National Medical Products Administration of the People's Republic of China to initiate a phase II clinical trial for the treatment of moderate-to-severe asthma....
International Biopharma Industry Week Shanghai 2021 Opens
SHANGHAI, Oct. 15, 2021 /PRNewswire/ -- On October 11, the International Biopharma Industry Week Shanghai 2021, under the guidance of the Shanghai Biomedical Industry Development Leading Group, the inaugural International Biopharma Industry Week Shanghai (IBIWS) is co-hosted by Shanghai Biomedical Industry Promotion Center, E Fund Assets Management Co., Ltd., Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai Fosun Pharmaceutical (Group) Co.,...
Qiming’s Portfolio Company Abbisko Lists on Main Board of HKEx
SHANGHAI, Oct. 15, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Abbisko (SEHK:2256), a clinical-stage biopharmaceutical company, listed on the main board of the Hong Kong Stock Exchange on October 13. The issue price is HK$ 12.46 per share, representing a market cap of HK$ 8.753 billion. The stock started trading on October 15, as market trading was canceled...
Interim Results Of A Pioneering Combination Study In Argentina With More Than 1,000 Participants Confirm The One-shot Sputnik Light Vaccine (The First Component Of The Sputnik V Vaccine) Is...
One-shot Sputnik Light is the first component of the Sputnik V vaccine, the world's first registered vaccine against coronavirus. Sputnik V pioneered the heterogeneous boosting approach (a "vaccine cocktail" using human adenovirus serotype 26 as the first component and human adenovirus serotype 5 as the second component). This approach is now also studied and followed by other vaccine...
Global Healthcare Accreditation (GHA) Partners with Khon Kaen province in Thailand and Ratchaphruek Hospital to Support Businesses with Best Practices regarding Safety, Health, and Well-being
WEST PALM BEACH, Fla., Oct. 15, 2021 /PRNewswire/ -- Global Healthcare Accreditation (GHA), The Khon Kaen Chamber of Commerce and Ratchaphruek Hospital, have announced the signing of a Memorandum of Understanding to support local businesses in the province of Khon Kaen, Thailand with best practices regarding safety, health, and well-being. Through this innovative partnership, GHA will collaborate with the Khon Kaen Chamber...
GV20 Oncotherapy Completes Series B Financing to Advance Pipeline into the Clinic and Expand Immuno-Oncology Drug Discovery Platform
SHANGHAI, Oct. 14, 2021 /PRNewswire/ -- GV20 Oncotherapy, a biotechnology company with unique expertise in novel target identification and antibody drug discovery in immuno-oncology, today announced the completion of its Series B financing. This round of financing was led by Coatue Management, with participation from existing investors IDG Capital, 3W Investment, Watson Capital, Linear Capital, and additional investors. ...
Pioneering Technology Companies and Global Innovators join FII Institute for 5th Anniversary of FII
RIYADH, Saudi Arabia, Oct. 14, 2021 /PRNewswire/ -- From flying cars to space technology, plus drones, satellites and video calls, the biggest names in technology and innovation are partnering with the Future Investment Initiative (FII) Institute. Some of the world's best pioneering technology companies and startups have partnered with the Institute ahead of the 5th anniversary of FII on...
Posture360 Receives Venture Capital to Drive Growth in Healthcare Industry
NEW YORK, Oct. 14, 2021 /PRNewswire/ -- Posture360, an industry leader in smart wearable technologies, has received an investment from Legendary Ventures as it is set to launch PostureSense®, the next-generation Smart Shirt that tracks, monitors, and analyzes physical activities (with real-time bio-feedback) through its SaaS platform to improve people's posture. The PostureSense® Smart Shirt helps individuals develop...
Gan & Lee Pharmaceuticals Concludes Phase 3 Studies of Gan & Lee Insulin Glargine (GL-GLA)
BEIJING and BRIDGEWATER, N.J., Oct. 14, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee) (Shanghai: 603087.SH), is pleased to announce the completion of two randomized, multicenter, phase 3 studies that compare proposed biosimilar Gan & Lee insulin glargine (GL-GLA) to a reference biologic. The two studies were conducted separately in subjects...
Roan Holdings Group Announces Agreement to Set Up Joint Venture to Expand in Consumer Health Services Market
BEIJING and HANGZHOU, China, Oct. 14, 2021 /PRNewswire/ -- Roan Holdings Group Co., Ltd. ("Roan" or the "Company") (OTC Pink: RAHGF and RONWF), a provider of diversified solutions in financial, insurance and healthcare related products and management services, today announced that the Company's subsidiary, Yifu Health Industry (Ningbo) Co., Ltd. ("Yifu") has signed a cooperation agreement (the "Agreement") with...
